Studying the Relationship Between Contact Lens Packaging Solutions and Bacterial Binding to Surface Eye Cells
This study has been completed.
Sponsor:
University of Texas Southwestern Medical Center
Information provided by:
University of Texas Southwestern Medical Center
ClinicalTrials.gov Identifier:
NCT01104961
First received: April 9, 2010
Last updated: October 13, 2010
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The goal of this study is to investigate the overall theory that the use of chemically preserved solutions associated with contact lenses promotes an increase in bacterial infection.
| Condition | Intervention |
|---|---|
|
Corneal Ulcer |
Device: Contact lens packaging solution Device: Balanced salt solution (BSS) |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Single Blind (Subject) Primary Purpose: Supportive Care |
| Official Title: | A Masked, Randomized, Prospective, Single Center Crossover Clinical Trial on the Relationship Between Chemically Preserved Contact Lens Packaging Solutions and Bacterial Binding to Corneal Epithelial Cells |
Resource links provided by NLM:
Genetics Home Reference related topics:
keratitis-ichthyosis-deafness syndrome
Drug Information available for:
Sodium chloride
U.S. FDA Resources
Further study details as provided by University of Texas Southwestern Medical Center:
Primary Outcome Measures:
- Bacterial binding of Pseudomonas Aeruginosa [ Time Frame: 5 weeks ] [ Designated as safety issue: No ]Counting the number of bacteria that bind to surface epithelial cells.
| Estimated Enrollment: | 20 |
| Study Start Date: | April 2010 |
| Study Completion Date: | August 2010 |
| Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Contact Lens Packaging Solution #1
Test solution - contact lens packaging solution
|
Device: Contact lens packaging solution
These test solutions are the intervention being tested.
Other Name: Blister pack solution
|
|
Experimental: Contact lens packaging solution #2
Test solution - contact lens packaging solution
|
Device: Contact lens packaging solution
These test solutions are the intervention being tested.
Other Name: Blister pack solution
|
|
Placebo Comparator: Balanced salt solution
Control solution
|
Device: Balanced salt solution (BSS)
BSS is isotonic to the tissues of the eyes.
Other Name: Saline solution
|
Detailed Description:
The purpose of this study is to investigate the theory of bacterial binding to surface eye cells through the use of chemically preserved solutions.
Eligibility| Ages Eligible for Study: | 18 Years to 38 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Age range: 18-38 years
- Any sex, race or national origin accepted as with our past studies. Minority representation will be proactively encouraged.
- No prior history of any contact lens wear within one month of entry into the study.
- No history of allergic eye disease either seasonal or associated with previous contact lens wear.
Exclusion Criteria:
- Any patient that is a current contact lens wearer.
- Patients with active ocular infection or inflammatory disease, history of herpetic keratitis, glaucoma, etc.
- Uncontrolled systemic disease or the presence of any significant illness or condition that could, in the judgment of the investigator, interfere with interpretation of the study results.
- Any patient using ocular tears, anti-histamine based ocular therapies, glaucoma therapy, vasoconstricting drops, etc.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01104961
Locations
| United States, Texas | |
| UT Southwestern Medical Center | |
| Dallas, Texas, United States, 75390 | |
Sponsors and Collaborators
University of Texas Southwestern Medical Center
Investigators
| Principal Investigator: | Danielle Robertson, OD, PhD | UT Southwestern Medical Center |
More Information
No publications provided
| Responsible Party: | Dr. Danielle Robertson, UT Southwestern |
| ClinicalTrials.gov Identifier: | NCT01104961 History of Changes |
| Other Study ID Numbers: | 032010-081 |
| Study First Received: | April 9, 2010 |
| Last Updated: | October 13, 2010 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Texas Southwestern Medical Center:
|
Bacterial infection Loss of epithelial cells |
Additional relevant MeSH terms:
|
Corneal Ulcer Ulcer Eye Infections Infection |
Keratitis Corneal Diseases Eye Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 21, 2013